An animal model with relevance to schizophrenia: Sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development

Neuroscience

Volumn 123, Issue 4, 2004, Pages 821-834

  Castagne V ^a   Cuenod M ^a   Do, K Q ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

Ascorbic acid; Behavior; Object recognition memory; Psychiatric diseases; Redox regulation; Sexual differentiation

Indexed keywords

ASCORBIC ACID; BUTHIONINE SULFOXIMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; GLUTATHIONE; PROTEIN SYNTHESIS INHIBITOR; VANOXERINE;

ADULTHOOD; AGE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BRAIN DEVELOPMENT; CATARACT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; EXPERIMENTAL RAT; FEMALE; HYPERACTIVITY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUTANT; NONHUMAN; OXIDATION REDUCTION REACTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RECOGNITION; SCHIZOPHRENIA; SENSORY DYSFUNCTION; SEX DIFFERENCE; WEIGHT GAIN;

EID: 1642482417     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.11.012     Document Type: Article

References (77)

1. Abbey H., Howard E. Statistical procedure in developmental studies on species with multiple offspring. Dev Psychobiol. 6:1973;329-335.
2. Astur R.S., Klein R.L., Mumby D.G., Protz D.K., Sutherland R.J., Martin G.M. A role for olfaction in object recognition by normal and hippocampal-damaged rats. Neurobiol Learn Mem. 78:2002;186-191.
3. Berger-Sweeney J., Hohmann C.F. Behavioral consequences of abnormal cortical development insights into developmental disabilities . Behav Brain Res. 86:1997;121-142.
4. Boksa P., El Khodor B.F. Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models possible implications for schizophrenia and other disorders . Neurosci Biobehav Rev. 27:2003;91-101.
5. Bowman R.E., Beck K.D., Luine V.N. Chronic stress effects on memory sex differences in performance and monoaminergic activity . Horm Behav. 43:2003;48-59.
6. Brown M.W., Aggleton J.P. Recognition memory what are the roles of the perirhinal cortex and hippocampus? Nat Rev Neurosci. 2:2001;51-61.
7. Budygin E.A., Kilpatrick M.R., Gainetdinov R.R., Wightman R.M. Correlation between behavior and extracellular dopamine levels in rat striatum comparison of microdialysis and fast-scan cyclic voltammetry . Neurosci Lett. 281:2000;9-12.
8. Buonocore G., Perrone S., Bracci R. Free radicals and brain damage in the newborn. Biol Neonate. 79:2001;180-186.
9. Bussey T.J., Muir J.L., Aggleton J.P. Functionally dissociating aspects of event memory the effects of combined perirhinal and postrhinal cortex lesions on object and place memory in the rat . J Neurosci. 19:1999;495-502.
10. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia new evidence . Annu Rev Pharmacol Toxicol. 41:2001;237-260.
11. Castagné V, Rougemont M, Cuénod M, Do KQ (2004) Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia. Neurobiol Dis 15:93-105.
12. Castagné V., Gautschi M., Lefèvre K., Posada A., Clarke P.G.H. Relationships between neuronal death and the cellular redox status focus on the developing nervous system . Prog Neurobiol. 59:1999;397-423.
13. Castagné V., Maire J.C., Moënnoz D., Gyger M. Effect of threonine on the behavioural development of the rat. Pharmacol Biochem Behav. 52:1995;281-289.
14. Chan S.W., Reade P.C. Determination of the L-ascorbic acid requirements in Wistar osteogenic disorder Shionogi rats for prolonged carcinogenesis experiments. Lab Anim. 30:1996;337-346.
15. Chen N., Reith M.E. Structure and function of the dopamine transporter. Eur J Pharmacol. 405:2000;329-339.
16. Crawford C.A., Williams M.T., Newman E.R., McDougall S.A., Vorhees C.V. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content. Synapse. 48:2003;131-137.
17. Cruz-Aguado R., Almaguer-Melian W., Díaz C.M., Lorigados L., Bergado J. Behavioral and biochemical effects of glutathione depletion in the rat brain. Brain Res Bull. 55:2001;327-333.
18. Danion J.M., Rizzo L., Bruant A. Functional mechanisms underlying impaired recognition memory and conscious awareness in patients with schizophrenia. Arch Gen Psychiatry. 56:1999;639-644.
19. Dellu F., Mayo W., Cherkaoui J., Le Moal M., Simon H. A two-trial memory task with automated recording study in young and aged rats . Brain Res. 588:1992;132-139.
20. Do K.Q., Lauer C.J., Schreiber W., Zollinger M., Gutteck-Amsler U., Cuénod M., Holsboer F. gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 65:1995;2652-2662.
21. Do K.Q., Trabesinger A.H., Kirsten-Krüger M., Lauer C.J., Dydak U., Hell D., Holsboer F., Boesiger P., Cuénod M. Schizophrenia glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo . Eur J Neurosci. 12:2000;3721-3728.
22. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev. 3:1979;79-83.
23. Dow-Edwards D.L., Busidan Y. Ontogenic cocaine effects evidence for multifactorial mechanisms . Ann NY Acad Sci. 846:1998;382-385.
24. Dow-Edwards D.L., Busidan Y. Behavioral responses to dopamine agonists in adult rats exposed to cocaine during the preweaning period. Pharmacol Biochem Behav. 70:2001;23-30.
25. Ennaceur A., Aggleton J.P. The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav Brain Res. 88:1997;181-193.
26. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats 1. Behavioral data . Behav Brain Res. 31:1988;47-59.
27. Finlay J.M. Mesoprefrontal dopamine neurons and schizophrenia role of developmental abnormalities . Schizophr Bull. 27:2001;431-442.
28. Gabrovska V.S., Laws K.R., Sinclair J., McKenna P.J. Visual object processing in schizophrenia evidence for an associative agnosic deficit . Schizophr Res. 59:2003;277-286.
29. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 65:1998;446-453.
30. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 57:2000;65-73.
31. Gluck M.R., Jayatilleke E., Shaw S., Rowan A.J., Haroutunian V. CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res. 39:2000;63-71.
32. Grima G., Benz B., Parpura V., Cuenod M., Do K.Q. Dopamine-induced oxidative stress in neurons with glutathione deficit implication for schizophrenia . Schizophr Res. 62:2003;213-224.
33. Gutteridge J.M., Halliwell B. Free radicals and antioxidants in the year 2000 a historical look to the future . Ann NY Acad Sci. 899:2000;136-147.
34. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA. 93:1996;1956-1961.
35. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 28:(Suppl 2):2003;17-54.
36. Heckers S., Curran T., Goff D., Rauch S.L., Fischman A.J., Alpert N.M., Schacter D.L. Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia. Biol Psychiatry. 48:2000;651-657.
37. Heimer L. Basal forebrain in the context of schizophrenia. Brain Res Brain Res Rev. 31:2000;205-235.
38. Herken H., Uz E., Ozyurt H., Sögüt S., Virit O., Kyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry. 6:2001;66-73.
39. Irwin S. Comprehensive observational assessment a systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse . Psychopharmacologia. 13:1968;222-257.
40. Kirkby R.J. A maturation factor in spontaneous alternation. Nature. 215:1967;784.
41. Lencz T., Bilder R.M., Turkel E., Goldman R.S., Robinson D., Kane J.M., Lieberman J.A. Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia. Arch Gen Psychiatry. 60:2003;238-243.
42. Lou M.F. Thiol regulation in the lens. J Ocul Pharmacol Ther. 16:2000;137-148.
43. Luine V.N., Jacome L.F., Maclusky N.J. Rapid enhancement of visual and place memory by estrogens in rats. Endocrinology. 144:2003;2836-2844.
44. Mahadik S.P., Evans D., Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 25:2001;463-493.
45. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia following a trail of evidence from cradle to grave . Dev Psychopathol. 12:2000;501-527.
46. Martensson J., Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats ascorbate spares glutathione and protects . Proc Natl Acad Sci USA. 88:1991;4656-4660.
47. Martensson J., Meister A. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proc Natl Acad Sci USA. 89:1992;11566-11568.
48. McCarty C.A., Wood C.A., Fu C.L., Livingston P.M., Mackersey S., Stanislavsky Y., Taylor H.R. Schizophrenia, psychotropic medication, and cataract. Ophthalmology. 106:1999;683-687.
49. McEwen B.S. Estrogens effects on the brain multiple sites and molecular mechanisms . J Appl Physiol. 91:2001;2785-2801.
50. McEwen B.S., Alves S.E. Estrogen actions in the central nervous system. Endocrinol Rev. 20:1999;279-307.
51. McEwen B.S., Alves S.E., Bulloch K., Weiland N.G. Ovarian steroids and the brain implications for cognition and aging . Neurology. 48:1997;S8-15.
52. Meister A. Glutathione biosynthesis and its inhibition. Methods Enzymol. 252:1995;26-30.
53. Melnick S.M., Kubie J.L., Laungani R., Dow-Edwards D.L. Impairment of spatial learning following preweaning cocaine exposure in the adult rat. Neurotoxicol Teratol. 23:2001;445-451.
54. Morrow B.A., Elsworth J.D., Roth R.H. Prenatal cocaine exposure disrupts non-spatial, short-term memory in adolescent and adult male rats. Behav Brain Res. 129:2002;217-223.
55. Mumby D.G., Glenn M.J., Nesbitt C., Kyriazis D.A. Dissociation in retrograde memory for object discriminations and object recognition in rats with perirhinal cortex damage. Behav Brain Res. 132:2002;215-226.
56. Nanda D., Tolputt T., Collard K.J. Changes in brain glutathione levels during postnatal development in the rat. Dev Brain Res. 94:1996;238-241.
57. Nishikimi M., Yagi K. Biochemistry and molecular biology of ascorbic acid biosynthesis. Subcell Biochem. 25:1996;17-39.
58. Park S., Püschel J., Sauter B.H., Rentsch M., Hell D. Visual object working memory function and clinical symptoms in schizophrenia. Schizopr Res. 59:2002;261-268.
59. Parnas J., Bovet P., Innocenti G.M. Schizophrenic trait features, binding, and cortico-cortical connectivity a neurodevelopmental pathogenic hypothesis . Neurol Psychiatr Brain Res. 4:1996;185-196.
60. Rabinovic A.D., Hastings T.G. Role of endogenous glutathione in the oxidation of dopamine. J Neurochem. 71:1998;2071-2078.
61. Rao M.L., Kölsch H. Effects of estrogen on brain development and neuroprotection implications for negative symptoms in schizophrenia . Psychoneuroendocrinology. 28:(Suppl 2):2003;83-96.
62. Rougemont M., Do K.Q., Castagné V. New model of glutathione deficit during development effect on lipid peroxidation in the rat brain . J Neurosci Res. 70:2002;774-783.
63. Ruigomez A., Garcia Rodriguez L.A., Dev V.J., Arellano F., Raniwala J. Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology. 11:2000;620-623.
64. Sawada H., Shimohama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev. 24:2000;143-147.
65. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 30:2001;1191-1212.
66. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem. 267:2000;4904-4911.
67. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients application of a three-dimensional, stereologic counting method . J Comp Neurol. 392:1998;402-412.
68. Shi X., Yin R., Dow-Edwards D.L. Chronic haloperidol alters dopamine receptors effects of cocaine exposure during the preweaning period . Eur J Pharmacol. 370:1999;241-249.
69. Shukitt-Hale B., Denisova N.A., Strain J.G., Joseph J.A. Psychomotor effects of dopamine infusion under decreased glutathione conditions. Free Radic Biol Med. 23:1997;412-418.
70. Shukitt-Hale B., Erat S.A., Joseph J.A. Spatial learning and memory deficits induced by dopamine administration with decreased glutathione. Free Radic Biol Med. 24:1998;1149-1158.
71. Smart J.L. Vulnerability of developing brain to undernutrition. Ups J Med Sci. 48:(Suppl):1990;21-41.
72. Spencer K.M., Nestor P.G., Niznikiewicz M.A., Salisbury D.F., Shenton M.E., McCarley R.W. Abnormal neural synchrony in schizophrenia. J Neurosci. 23:2003;7407-7411.
73. Steckler T., Sahgal A., Aggleton J.P., Drinkenburg W.H. Recognition memory in rats III. Neurochemical substrates . Prog Neurobiol. 54:1998;333-348.
74. Tek C., Gold J., Blaxton T., Wilk C., McMahon R.P., Buchanan R.W. Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry. 59:2002;146-153.
75. Whimbey A.E., Denenberg V.H. Two independent behavioral dimentions in open-field performance. J Comp Physiol Psychol. 63:1967;500-504.
76. Yao J.K., Leonard S., Reddy R.D. Reduced glutathione redox state in schizophrenia. J Neurochem. 81:(Suppl 1):2002;22.
77. Yao J.K., Reddy R.D., van Kammen D.P. Oxidative damage and schizophrenia an overview of the evidence and its therapeutic implications . CNS Drugs. 15:2001;287-310.